Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities

@article{Ohtsuki2012SimultaneousAP,
  title={Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities},
  author={Sumio Ohtsuki and Olaf Schaefer and Hirotaka Kawakami and Tae Inoue and Stephanie Liehner and Asami Saito and Naoki Ishiguro and Wataru Kishimoto and Eva Ludwig-Schwellinger and Thomas Ebner and Tetsuya Terasaki},
  journal={Drug Metabolism and Disposition},
  year={2012},
  volume={40},
  pages={83 - 92}
}
The purpose of the present study was to determine the absolute protein expression levels of multiple drug-metabolizing enzymes and transporters in 17 human liver biopsies, and to compare them with the mRNA expression levels and functional activities to evaluate the suitability of the three measures as parameters of hepatic metabolism. Absolute protein expression levels of 13 cytochrome P450 (P450) enzymes, NADPH-P450 reductase (P450R) and 6 UDP-glucuronosyltransferase (UGT) enzymes in… 

Tables from this paper

Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.

expression levels of CYP1A2 and GLUT4 were significantly correlated with body-mass index and the levels of 4F2hc showed significant gender differences, and changes in molecular mechanisms of jejunal metabolism and transport in morbidly obese patients were understood.

Estimation of fraction of drug metabolism by a single UDP‐glucuronosyl transferase enzyme using relative expression factor

This study provided useful information on REF values, which promote a robust estimation of fmUGT values for UGT substrates when evaluating the contribution of UGT isoforms to total metabolic clearance.

The reference liver—CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype

This study aimed to compare mRNA expression and protein abundance of the most pharmacologically relevant drug-metabolizing enzymes in two main sources of the control liver samples that are used as the reference, i.e. organ donor livers and non-tumorous tissue from metastatic livers.

Protein Abundance of Clinically Relevant Drug‐Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens

This work revises and complements existing findings on the distribution of drug‐metabolizing enzymes in the first‐pass effect organs and explored gene expression and protein abundance of CYP1A2 and CYP2B6 in paired tissues from nine organ donors to contribute to improved understanding of hepatic and intestinal drug metabolism.

Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex

Drug companies should include UGT2B17 in early phenotyping assays during drug discovery to avoid late clinical failures, and these data can be used to predict variability in the metabolism of UGT1B17 substrates.

Preparation of a Specific Monoclonal Antibody against Human UDP-Glucuronosyltransferase (UGT) 1A9 and Evaluation of UGT1A9 Protein Levels in Human Tissues

It is found that UGT1A9 protein is expressed in the kidney and the liver but not in the jejunum or the ileum, consistent with previous reports of mRNA expression, suggesting the importance of evaluating UGT isoform expression at protein levels.

Correlation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver

There was a strong association between POR and the expression of P450 isoforms at the mRNA and protein level, whereas the relationship at the activity level, as well as the effect of POR protein content on P450 activity, was less pronounced.

Physiological Content and Intrinsic Activities of 10 Cytochrome P450 Isoforms in Human Normal Liver Microsomes

Some single nucleotide polymorphisms had obvious effects on P450 expression in human normal livers and the effects of gene polymorphisms on intrinsic P450 activity at the isoform level were quite different from those at the microsomal level, which might be due to changes in P450 protein content.
...

References

SHOWING 1-10 OF 41 REFERENCES

Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression

Assessment of the possibility of a structural variant of CYP3A4 through evaluation of the standard deviation relative to the mean kinetic constant value suggests that structural mutation of CYp3A 4 may not be a major factor affecting interindividual variation in CYP 3A4 metabolic function.

Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver.

This fact indicates that CYP2E1, in addition to being less variable between individuals than CYP3A4, differs in its regulation mechanism.

Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection.

This highly sensitive and selective quantification method is a useful tool for the analysis of highly homologous CYP isoforms and the contribution made by each CyP isoform to drug metabolism.

Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients.

The results suggest the metabolic capacity of CYP2C19 in Japanese small intestine may play as important a role as the liver in drug metabolism.

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

The results indicate that the majority of human CYP 1A xenobiotic inhibitor and substrate probes are nonspecific in their recognition of CYP1A1 and CYp1A2, although selectivity is apparent for some compounds.

Developmental Expression of the Major Human Hepatic CYP3A Enzymes

The objective of this study was to characterize the developmental expression of hepatic CYP3A forms from early gestation to 18 years of age using up to 212 fetal and pediatric liver samples and based on immunoquantitation, CYP 3A5 protein expression was found to be highly variable, generally independent of age, and more frequently observed for African-American individuals.

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

The results presented in this study provide useful information for the study of drug biotransformation in humans and for the basis of drug toxicities, carcinogenesis and teratogenesis.

Reliability and robustness of simultaneous absolute quantification of drug transporters, cytochrome P450 enzymes, and Udp-glucuronosyltransferases in human liver tissue by multiplexed MRM/selected reaction monitoring mode tandem mass spectrometry with nano-liquid chromatography.

It is demonstrated, for the first time, that the MS-based assay with nano-liquid chromatography provides adequate reliability and robustness for the quantification of selected drug transporters, P450 enzymes and UGTs.

Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.

The extensive investigation of gene and protein patterns of transporters and metabolizing enzymes provides new molecular information for understanding drug entry and metabolism in the human blood-brain barrier.

Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.

  • M. Court
  • Biology, Medicine
    Methods in enzymology
  • 2005